<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04674592</url>
  </required_header>
  <id_info>
    <org_study_id>BioFACTS</org_study_id>
    <nct_id>NCT04674592</nct_id>
  </id_info>
  <brief_title>Biomarkers in the Diagnosis of Acute Compartment Syndrome</brief_title>
  <acronym>BioFACTS</acronym>
  <official_title>Biomarkers of Rhabdomyolysis in the Diagnosis of Acute Compartment Syndrome: Study Protocol of a Prospective Multinational, Multicentre Study in Patients With Tibial Fractures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Research Council of Southeast Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective multinational, multicentre cohort study aims to investigate the hypothesis&#xD;
      that biomarkers of muscle cell damage can predict acute compartment syndrome in patients with&#xD;
      tibial fractures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with a tibial fracture are included. P-myoglobin and P-creatine phosphokinase are&#xD;
      analysed at 6-hourly intervals pre- and if applicable, postoperatively after surgical&#xD;
      fixation or fasciotomy. Also, blood samples will be collected in 6 hourly intervals if acute&#xD;
      compartment syndrome is suspected. An expert panel of senior orthopaedic surgeons will&#xD;
      retrospectively assess study data and classify patients who had undergone fasciotomy into&#xD;
      those with and without acute compartment syndrome.&#xD;
&#xD;
      Blood samples will also be collected in patients with acute compartment syndrome without&#xD;
      tibial fractures, to serve as a positive control group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2018</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peak levels of P-myoglobin and P-creatine phosphokinase</measure>
    <time_frame>Up to 5 days</time_frame>
    <description>A series of blood samples will be collected with 6-hourly interval at the following time-points:&#xD;
Admission to hospital: P-myoglobin and P-creatine phosphokinase are collected at 6-hourly intervals for a maximum of 48 hours or until definitive surgical fixation of the fracture is performed (temporary external fixation excluded).&#xD;
Surgical fracture treatment: After surgical intervention (definitive surgical fracture treatment, excluding temporary external fixation), another series of blood samples is collected with 6-hourly interval for 24 hours.&#xD;
Acute compartment syndrome: If suspicion of acute compartment syndrome emerges, blood samples will be collected with 6-hourly interval until fasciotomy is performed or the suspicion is written off. After fasciotomy, blood samples will be continued with 6-hourly interval for 24 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MicroRNA</measure>
    <time_frame>Up to 5 days</time_frame>
    <description>We also collect microRNA specific for muscle damage at the same time intervals and use it as an objective measures of muscle damage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histological evidence of muscle damage</measure>
    <time_frame>At internal fixation and/or fasciotomy</time_frame>
    <description>At surgery (internal fixation or fasciotomy) biopsies are taken from tibialis anterior muscle in some centres for further histological analysis. Two biopsies are taken from the fractured leg, one near the fracture and one at distance, and one biopsy from the uninjured leg (control). Biopsies are frozen within 30 minutes using liquid nitrogen and isopentane and stored in minus 80 degrees Celsius.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Acute Compartment Syndrome</condition>
  <condition>Tibia Fracture</condition>
  <arm_group>
    <arm_group_label>Tibial fracture</arm_group_label>
    <description>Patients with a traumatic tibial fracture and without acute compartment syndrome.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tibial fracture complicated by acute compartment syndrome</arm_group_label>
    <description>Patients with a tibial fracture and acute compartment syndrome of fractured leg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute compartment syndrome without fracture</arm_group_label>
    <description>Patients with acute compartment syndrome but without a fracture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood samples and biopsies</intervention_name>
    <description>Blood samples for analysis of biomarkers of muscle damage. Muscle biopsies for histological analysis of muscle damage.</description>
    <arm_group_label>Acute compartment syndrome without fracture</arm_group_label>
    <arm_group_label>Tibial fracture</arm_group_label>
    <arm_group_label>Tibial fracture complicated by acute compartment syndrome</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples, muscle biopsies&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a traumatic tibial fracture with or without other concomitant fractures and&#xD;
        patients with suspected acute compartment syndrome. The study population is sampled in a&#xD;
        consecutive way.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Tibial fracture group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
        - Traumatic tibial fracture&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Malignancy&#xD;
&#xD;
          -  Acute myocardial infarction&#xD;
&#xD;
          -  Kidney failure (GFR ≤35 ml/min)&#xD;
&#xD;
          -  Muscle disease&#xD;
&#xD;
          -  Paraplegia/tetraplegia&#xD;
&#xD;
        Non-fracture group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
        - Suspected acute compartment syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Malignancy&#xD;
&#xD;
          -  Acute myocardial infarction&#xD;
&#xD;
          -  Kidney failure (GFR ≤35 ml/min)&#xD;
&#xD;
          -  Muscle disease&#xD;
&#xD;
          -  Paraplegia/tetraplegia&#xD;
&#xD;
          -  Associated fracture&#xD;
&#xD;
          -  Acute vascular event&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jörg Schilcher, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Linkoeping</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jörg Schilcher, MD, PhD</last_name>
    <phone>+46101030000</phone>
    <email>jorg.schilcher@liu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Abraham Nilsson, MD</last_name>
    <phone>+46101030000</phone>
    <email>abraham.nilsson@regionostergotland.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University hospital of Linkoping</name>
      <address>
        <city>Linkoping</city>
        <zip>581 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Schilcher, MD, PhD</last_name>
      <phone>+46101030000</phone>
      <email>jorg.schilcher@liu.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 13, 2020</study_first_submitted>
  <study_first_submitted_qc>December 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2020</study_first_posted>
  <last_update_submitted>December 13, 2020</last_update_submitted>
  <last_update_submitted_qc>December 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Jörg Schilcher</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compartment Syndromes</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

